XML 14 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Note 1 - Basis of Presentation
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]
1.
           Basis of Presentation:
 
The accompanying unaudited financial statements have been prepared by Kidoz Inc. ("the Company") in conformity with accounting principles generally accepted in the United States of America ("US GAAP") applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission.  Accordingly, certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations.  In the opinion of management, the unaudited interim consolidated financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented.  All adjustments are of a normal recurring nature, except as otherwise noted below.  These unaudited interim consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto for the year ended
December 31, 2019,
included in the Company's Annual Report on Form
10
-K, filed
April 22, 2020,
with the Securities and Exchange Commission.  The results of operations for the interim periods are
not
necessarily indicative of the results of operations for any other interim period or for a full fiscal year.
 
Continuing operations
 
These unaudited interim consolidated financial statements have been prepared on the going concern basis, which presumes the realization of assets and the settlement of liabilities in the normal course of operations.  The application of the going concern basis is dependent upon the Company achieving profitable operations to generate sufficient cash flows to fund continued operations, or, in the absence of adequate cash flows from operations, obtaining additional financing.  The Company has reported losses from operations for the
nine
months ended
September 30, 2020
and
2019
and has an accumulated deficit of
$41,201,141
as at
September 30, 2020. 
These material uncertainties raise substantial doubt about the Company's ability to continue as a going concern.
 
In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts and settlement of the liability amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to succeed in its future operations. The financial statements do
not
include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
 
Management continues to review operations in order to identify additional strategies designed to generate cash flow, improve the Company's financial position, and enable the timely discharge of the Company's obligations.  If management is unable to identify sources of additional cash flow in the short term, it
may
be required to further reduce or limit operations.
 
In
March 2020
the World Health Organization declared coronavirus COVID-
19
a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, has led to an economic downturn. It has also disrupted the normal operations of many businesses, including the Company's. In early
March 2020,
the Company employees commenced working from home and commenced social distancing. This outbreak has decreased spending, adversely affecting demand for the Company's product and has harmed the Company's business and results of operations. It is
not
possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and at this time its full effects on the Company's business, its future results of operations or ability to raise funds.